Download PDF

Other users also viewed these articles

Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018¿2024) Nahum Méndez-Sánchez; Mariana M. Ramírez-Mejía; Carlos Cortez-Hernández; Elianee M. Tovar-Bojorquez; Raúl Contreras-Omaña; Juan D. Monsiváis-Morales; Jacqueline Cordova-Gallardo; Mauricio Castillo-Barradas; Nubia Guzmán-Rodríguez; María S. González-Huezo; Adrian Sandez-Araiza; Eira Cerda-Reyes; Stefanny Cornejo-Hernández; Beatriz Barranco-Fragoso; Ana D. Cano-Contreras; José M. Remes-Troche; Fatima Higuera-de-la-Tijera; José L. Pérez-Hernández; Norberto Chávez-Tapia; Francisco J. Valentin-Cortez; Iaarah Montalvo-Gordon; Rubén R. Lozano-Salazar; Montserrat Sabanes-Hernández; Itziar Borbolla-Schega; Heriberto Rodríguez-Hernández;
10.1016/j.aohep.2025.102131
Clinical and molecular implications of antipsychotics in MASLD Celina Gonzalez; Misael Uribe; Norberto C. Chavez-Tapia;
10.1016/j.aohep.2025.102158